Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience. - Wikidata - awgldk - TriplyDB

Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.

Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.

http://www.wikidata.org/entity/Q37015759

about

Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years Recent translational research into targeted therapy for liposarcoma.Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram?Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case report.Giant myxoid liposarcoma of the gluteal region: case report of patient caused delay of surgical treatment and review of the literature Retroperitoneal dedifferentiated liposarcoma: Analysis of 61 cases from a large institution Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection

P2860

Q33792322-7EAE8C83-67B7-476D-965E-7B6CFF0D28B2 Q39265801-4490B633-1623-4F82-BF94-39918D8A8810 Q41180131-B59D1840-B9B6-416D-BED8-8D0D9DE91BEB Q41307028-65BFD3C8-272E-4C72-9CE5-461F3D40229B Q57481781-1DE6C6B2-1457-4DFF-B55E-B560DADB3453 Q58582227-BE0B06EE-D415-4EED-A637-0080C7100552 Q58698876-32C3A1AE-CE2C-4EF5-946D-A74714271BD5

P2860

Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.

http://www.wikidata.org/entity/Q37015759

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic Model to Predict Su ...... ulti-Institutional Experience.

@en

Prognostic Model to Predict Su ...... ulti-Institutional Experience.

@nl

type

label

Prognostic Model to Predict Su ...... ulti-Institutional Experience.

@en

Prognostic Model to Predict Su ...... ulti-Institutional Experience.

@nl

prefLabel

Prognostic Model to Predict Su ...... ulti-Institutional Experience.

@en

Prognostic Model to Predict Su ...... ulti-Institutional Experience.

@nl

P1433

Q37015759-1B7AE76D-5BEB-4441-A78E-010BFAD82756

P1476

Q37015759-22D6A9D6-0A31-413E-AA9A-56AA4138398A

P2093

Q37015759-0173F3D9-92CC-4401-A36C-4CA96F54FE7A

Q37015759-080D5CCB-25FD-41C3-9963-58136D9C821F

Q37015759-09663B24-0793-4ECF-A782-8CB506CBDF03

Q37015759-12D3DB31-8A32-4777-AD94-F6FB94E819E7

Q37015759-3E26BCE7-3D57-4265-A0D1-BEC0A00A58EB

Q37015759-4367295A-99E2-491C-8B18-30D3E51842A6

Q37015759-65E5A100-FB31-4865-B030-19B1E3F8CBAB

Q37015759-85ACC769-369D-4ED1-8621-259A351ED4AD

Q37015759-8D371DD0-081A-432C-8FF8-3376CD0785F6

Q37015759-B2274F8D-577A-4219-808C-BAD378A30C4A

P2860

Q37015759-08693A00-103C-49E4-9CD8-655943CF77C4

Q37015759-137CF60E-09E4-4998-B2B0-446453CAA1AE

Q37015759-44075186-F6B8-4165-AC43-419FD442C1BF

Q37015759-472C8EB7-C2B0-4E45-BECA-2C305E362442

Q37015759-4C5A543C-E23B-40BB-9204-AF53793370C6

Q37015759-50041F9B-B927-4A6E-B676-64DBF3906B63

Q37015759-630AD0CF-77CB-4F37-A696-6C668410B14C

Q37015759-6A6824EF-FBA4-40F6-A537-13E27CC1CF5D

Q37015759-82794F12-C9E6-4ACE-8F6E-ECB92E919180

Q37015759-9EF2034A-7AFE-4C89-AC53-58853A5F2D60

P304

Q37015759-54AFD16E-160C-4354-A2F4-D5D7A5B41E6F

P31

Q37015759-B20D729C-8397-4CDC-B9E3-13E3E6709752

P356

Q37015759-D215642E-667F-4F47-9508-DC57369B2A0A

P433

Q37015759-99BDC38E-FA88-460F-95CE-29BB5C662780

P478

Q37015759-D7DCD6D9-FF64-49A5-A57D-1DEBD3FE9B1C

P50

Q37015759-0349B247-073B-4D59-99C8-D6980E973576

Q37015759-1D50E42F-E156-4A20-9BD6-CB158F50BE42

Q37015759-2A63C541-7D1F-41D6-8FE2-AC13DDA0BD1C

Q37015759-43AB5818-5B83-4AC4-A867-E6C311C50B6F

Q37015759-C295D85F-42E0-450B-9A95-B92347FC9006

P577

Q37015759-47B0045B-06AB-487C-8697-FC02FE698A58

P698

Q37015759-766C232D-5D9A-48D8-8948-DF3DFC706D1A

P932

Q37015759-2042F7ED-EDAC-486F-B2B2-ABA5FF6E353B

P356

P1433

Journal of Cancer

P1476

Prognostic Model to Predict Su ...... ulti-Institutional Experience.

@en

P2093

Hyo Song Kim

http://www.w3.org/2001/XMLSchema#string

Hyun Jung Jun

http://www.w3.org/2001/XMLSchema#string

Jeeyun Lee

http://www.w3.org/2001/XMLSchema#string

Ki Hyang Kim

http://www.w3.org/2001/XMLSchema#string

Kyoo-Ho Shin

http://www.w3.org/2001/XMLSchema#string

Kyung Sik Kim

http://www.w3.org/2001/XMLSchema#string

Se Hoon Park

http://www.w3.org/2001/XMLSchema#string

Seong Yoon Yi

http://www.w3.org/2001/XMLSchema#string

Seung Hoon Beum

http://www.w3.org/2001/XMLSchema#string

Sung Hoon Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Metastatic patterns of myxoid/round cell liposarcoma: a review of a 25-year experience

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy.

Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

Liposarcoma in children and young adults: a multi-institutional experience.

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series

Advances in the targeted therapy of liposarcoma.

Retroperitoneal liposarcoma: current insights in diagnosis and treatment

P304

1174-1180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.15243

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Young Deuk Choi

P577

2016-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27326262

http://www.w3.org/2001/XMLSchema#string

P932

4911886

http://www.w3.org/2001/XMLSchema#string